Drug Shortage Report for LENVIMA
Report ID | 76473 |
Drug Identification Number | 02468220 |
Brand name | LENVIMA |
Common or Proper name | Lenvatinib |
Company Name | EISAI LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | LENVATINIB |
Strength(s) | 8MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 8mg daily-dose carton containing 6 blister cards (each 5-day blister card contains ten 4mg capsules) |
ATC code | L01XE |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-02-19 |
Estimated end date | |
Actual end date | 2019-02-28 |
Shortage status | Resolved |
Updated date | 2019-03-01 |
Company comments | Supply of 4mg capsules available through other daily-dose configurations. Contact for more information. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6925 CENTURY AVE, SUITE 701 MISSISSAUGA, ONTARIO CANADA L5N 7K2 |
Company contact information | Tammy Mitchell-Moore - Director, Regulatory Affairs 905-814-2312 / tammy_mitchellmoore@eisai.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-02-21 | English | Compare |
v2 | 2019-02-21 | English | Compare |
v3 | 2019-02-21 | French | Compare |
v4 | 2019-03-01 | English | Compare |
v5 | 2019-03-01 | English | Compare |
v6 | 2019-03-01 | English | Compare |
v7 | 2019-03-01 | French | Compare |
v8 | 2019-03-01 | English | Compare |
v9 | 2019-03-01 | English | Compare |
v10 | 2019-03-01 | English | Compare |
v11 | 2019-03-01 | French | Compare |
Showing 1 to 11 of 11